|
|
||||||||
1 Department of Veterinary Physiology, 2 Department of Veterinary Anatomy, 3 Department of Veterinary Pathology, and 4 Department of Toxicology, College of Agriculture, Osaka Prefecture University, Sakai 599-8531; and 5 Department of Veterinary Anatomy, Faculty of Agriculture, Yamaguchi University, Yamaguchi 753-8515, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Changes
in body temperature and cell infiltration, mediated by cytokines
including tumor necrosis factor-
(TNF-
), occur during
inflammation, but a role of body temperature on inflammatory responses
remains obscure. Intraperitoneal injection of 10% casein to mice
resulted in transient hypothermia followed by neutrophil accumulation
in peritoneal cavities. Peritoneal TNF-
was rapidly raised, and
pretreatment of mice with an anti-TNF-
antibody promoted temperature
restoration and partially inhibited neutrophil accumulation. To
investigate direct effects of body temperature on neutrophils, peritoneal or peripheral blood neutrophils were cultured at 35°C or
37°C with or without recombinant murine TNF-
(100 ng/ml) or a
protein synthesis inhibitor cycloheximide (1 µg/ml). Significant inhibition of spontaneous and TNF-
-induced apoptosis was obtained at
35°C compared with 37°C, an effect that was not altered by the
addition of cycloheximide. Moreover, phagocytic ability of peritoneal
neutrophils was significantly enhanced by incubating them at the lower
temperature. These results indicate that mild hypothermia induced by
endogenous TNF-
has enhancing roles on neutrophil survival and
function during peritoneal inflammation.
inflammation; body temperature; tumor necrosis
factor-
| |
INTRODUCTION |
|---|
|
|
|---|
INFLAMMATION IS A COMPLEX cellular and biochemical
response to injurious stimuli and is regulated by an extensive network of cytokines. Above all, tumor necrosis factor-
(TNF-
) is well known to be released immediately after an injury to local tissue and to
play multiple roles in acute phase responses including recruitment of
neutrophils and fever. Neutrophils primarily accumulate and play a
pivotal role in host defense by phagocytosing and killing microbes or
scavenging irritants but are relatively short-lived and die by
apoptosis. TNF-
is known to stimulate neutrophil adhesion to
endothelial cells (11, 19) and to enhance phagocytosis and superoxide
production of neutrophils (1, 28). TNF-
, on the other hand, has been
reported to promote neutrophil apoptosis (31, 39, 41, 42, 46).
Fever is currently thought to be caused by endogenous pyrogens released
by macrophages and accessory cells during injury and inflammation, and
TNF-
as well as interleukin (IL)-1 and -6 are regarded as pyrogens
(22). Actually, there are several reports in which the injection of
TNF-
produced fever in human and experimental animals (30, 37). In
addition, polyclonal and monoclonal antibodies against TNF-
(anti-TNF) have been found to attenuate lipopolysaccharide (LPS)- and
turpentine-induced fever (4, 18, 29). However, Long et al. (26) have
shown opposite results, that is, anti-TNF further enhanced LPS-induced
fever, and Klir et al. (21) have reported that intraperitoneal
injection of human recombinant TNF-
attenuated LPS-induced fever in
rats. Moreover, hypothermia was observed immediately following
injection of relatively high concentrations of LPS in mice and rats,
and anti-TNF and TNF-
-soluble receptor prevented this (6, 23).
Furthermore, Leon et al. (24) just recently reported that TNF
p55/p75-receptor (TNFR) knockout mice attenuated hypothermia induced by
cecal ligation and puncture (CLP). These results suggest a possible
role for TNF-
not only as a pyrogen but also as an antipyretic
factor (cryogen) to limit the magnitude of fever or more actively lower
body temperature.
As to a physiological role of body temperature on neutrophil function,
it has been generally reported that mild hyperthermia (up to 40°C)
activates neutrophil function, but severe hyperthermia (more than
42°C) or hypothermia inhibits it (15, 44, 45, 47, 48). However,
most of the results were obtained from in vivo experiments in which
body temperature was changed physically or chemically or in vitro
experiments using peripheral blood neutrophils, some of whose
physiological characteristics are known to be different from those of
inflammatory or tissue neutrophils (2, 31, 49). Thus the present study
was performed to determine whether a physiological correlation between
neutrophil accumulation and changes in body temperature exists and the
role of endogenous TNF-
in this correlation during acute
inflammation by using mice injected intraperitoneally with casein.
Moreover, to investigate a possible role of changes in body temperature
on neutrophil function at an inflammatory site, we studied the effect
of different incubation temperatures within a physiological range on
apoptosis of neutrophils isolated from the casein-injected peritoneal
cavity and from normal peripheral blood and on phagocytic activity of
peritoneal neutrophils. Most of all, this is the first report
demonstrating that physiological temperature changes directly alter the
progress of neutrophil apoptosis.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Mice. Albino ICR mice (from Japan SLC, Hamamatsu, Japan) were raised in our laboratory, and male mice aged 2-3 mo were used in this study.
Measurement of body temperature. Rectal temperature was
measured using an electric thermometer with a probe (Muromachi Kikai, Tokyo, Japan) every 1 h after mice were injected intraperitoneally with
2 ml of various doses of LPS-free sodium caseinate (casein; Wako Pure
Chemical Industries, Osaka, Japan) in saline warmed to 37°C. A
mouse was put on a metal cover of a cage, and the tail was gently held,
then the probe was inserted 1.7 cm into the rectum. Experiments were
conducted after mice were trained for several days. In some
experiments, mice were preinjected with 1 ml polyclonal rabbit
anti-mouse TNF-
(Genzyme, Cambridge, MA) diluted 50-fold in saline
and warmed to 37°C 2 h before the injection of casein.
Isolation of peritoneal exudate cells. Isolation of peritoneal exudate cells (PEC) after casein injection was carried out by techniques previously described (16, 17). Briefly, mice were killed by decapitation 5 h after intraperitoneal injection of 10% casein, and PECs were collected by washing the peritoneum with MEM (Gibco BRL Life Technologies, Rockville, MD) containing 1% heparin. PECs, in which the population of neutrophils was greater than 80%, estimated by Giemsa staining, were used for the cultures.
Isolation of peripheral blood neutrophils. Heparinized peripheral blood was obtained from intact mice by cardiac puncture under pentobarbital sodium anesthesia (0.1 mg/100 g body wt). Neutrophils were purified by a method described by Tsuchida et al. (42). Briefly, the heparinized blood was mixed with an equal volume of 37°C plasma gel that had been prepared as follows. Three grams of gelatin, 0.7 g of NaCl, and 0.2 g of CaCl2 were dissolved in 100 ml distilled water at 60°C and stored at 4°C. The mixture of blood and plasma gel was allowed to stand until erythrocytes were settled. The leukocyte-rich supernatant was transferred to an another tube and washed with MEM. The pellet was suspended in 5 ml MEM and overlayered onto the same volume of Ficoll-Paque (sp. gr. 1.077; Amersham Pharmacia Biotech, Uppsala, Sweden), then centrifuged at 800 g for 10 min at 4°C. The pellet containing neutrophils and erythrocytes was allowed to lyse the erythrocytes with hypotonic NaCl and was washed with MEM twice. The purity of neutrophils was more than 75% (the remaining cells were mostly lymphocytes).
Cell culture. PECs were cultured in 24-well tissue culture
plates (Becton Dickinson, Tokyo, Japan). Each well contained
106 PECs in 1 ml
MEM (GIBCO) supplemented with 1%
newborn calf serum (NCS; GIBCO) with or without 100 ng/ml recombinant
mouse TNF-
(rmTNF-
; Pepro Tech, Rocky Hill, NJ) or 1 µg/ml
cycloheximide (CHX; Wako). Peripheral blood neutrophils were cultured
at 105 cells/100 µl in each well of 96-well plates
(Becton Dickinson). Plates were incubated at 35°C or 37°C in a
fully humidified atmosphere of 5% CO2 in air.
Examination of apoptosis. Morphological examination of apoptosis was performed by using Giemsa staining. Briefly, cells were spun in a cytocentrifuge (Cytospin; Shandon Scientific, Cheshire, Wales, UK) and were fixed in methanol followed by staining for 30 min with 10-times diluted Giemsa solution. Giemsa-stained preparations were observed under light microscopy (×400), and percentages of apoptotic neutrophils were estimated from 200 Giemsa-stained neutrophils per slide (16). Neutrophil apoptosis was also confirmed by staining with 1 µg/ml DNA-specific fluorochrome Hoechst 33258 under fluorescent microscopy.
Electrophoresis of DNA. Isolation and electrophoresis of PEC
DNA were carried out by a modification of a technique described by
Ishizawa et al. (14). Briefly, 5 × 105 PECs, cultured
with or without rmTNF-
at 35°C or 37°C, were suspended in
200 µl PBS in a 1.5-ml microfuge tube. Ten microliters proteinase K
(10 mg/ml; Sigma Chemical, St. Louis, MO), 10 µl RNase (10 mg/ml
ribonuclease A; Sigma), and 50 µl 5% SDS were added and incubated at
37°C for 30 min. After addition of 300 µl NaI solution and
incubation at 60°C for 15 min, 500 µl 100% isopropanol (Wako)
were added, then vigorously shaken, and allowed to stand for 15 min at
room temperature. The NaI solution contained 6 M sodium iodide (Wako),
13 mM EDTA (EDTA-Na, Wako), 0.5% sodium-N-lauroylsarcosinate (Wako), 10 mg/ml glycogen (Wako), and 26 mM Tris-HCl (pH 8, Wako). A
tube was centrifuged at 15,000 g for 15 min to precipitate DNA, the supernatant was discarded, 1 ml 50% isopropanol was added, and the
mixture was centrifuged at 15,000 g for 15 min. After the
supernatant was discarded, 1 ml 100% isopropanol was added and
centrifuged at 15,000 g for 15 min. The DNA precipitate was vacuum-dried and dissolved in 50 µl Tris-EDTA (TE) buffer at
4°C. TE buffer contained 100 µl 40 mM Tris-HCl, 10 µl 1 mM EDTA, and 890 µl ultrapurified water. Twenty five
microliters of each sample were mixed with 2 µl loading buffer
(0.25% bromophenol blue and 40% sucrose) and loaded into each well of
a 2% agarose gel containing 1 µg/ml ethidium bromide. As a molecular
size standard of DNA, 1 µl marker solution (Maker 4,
×174/Hae digest; Wako) was mixed with 24 µl TE buffer.
Electrophoresis was carried out at 100 V, 80 mA, until the marker dye
had migrated 3-4 cm.
TNF-
bioassay. TNF-
in a peritoneal exudate fluid (PEF)
was measured using a modification of a bioassay technique previously described (9). PEFs were frozen at
80°C until used. Assays were performed using TNF-
-sensitive L929 tumorigenic murine
fibroblast cell line. L929 cells were seeded at 104
cells/well in 100 µl DMEM (GIBCO) containing 10% NCS in a 96-well flat-bottom microtiter plate (Becton Dickinson) and incubated for 12 h
in 5% CO2 atmosphere at 37°C. The medium was discarded and replaced with 100 µl PEF solution diluted 40- to 80-fold by MEM
containing 5% NCS. To construct a dose-response curve, 100 µl of the
serial dilutions of rmTNF-
were added. One hundred microliters
actinomycin D (final concentration 1 mg/ml; Wako) were also added, and
a plate was incubated for 18 h. Supernatant was removed, and cells were
treated with 40 µl 2% crystal violet (in 25 mM methanol) for 20 min.
After 100 µl 0.5% SDS were added, absorbance was measured at 570 nm
on Immuno Reader NJ-2001 (Nippon InterMed, Tokyo, Japan). TNF-
values for PEF samples were determined from a standard curve generated
using rmTNF-
.
Phagocytosis assay. Phagocytosis was assessed using a modified
technique previously described (17). PECs were suspended at a
concentration of 2 × 105 cells/ml in
MEM
containing 1% NCS. Hydrophilic microsphere lumispheres (2-µm
diameter; Toray Research Center, Tokyo, Japan) were suspended at 2 × 108 microspheres/ml in PBS. Ten microliters
rmTNF-
(100 ng/ml) or MEM were mixed with 90 µl cell suspension
and 10 µl lumisphere solution. The mixture was incubated for 20 min
at 35°C or 37°C. To stop the phagocytic response, 1 ml cold PBS
was added. After centrifugation at 1,500 rpm for 5 min, 10 µl fuchsin
solution diluted 10-fold were added to the pellet. Extracellular
lumispheres were stained red with fuchsin, but they were transparent
when phagocytosed. Under light microscopy (×400), the percentages
of neutrophils phagocytosing more than one lumisphere were estimated from a total of 200 neutrophils.
Statistical analysis. ANOVA followed by Fisher's post hoc test (protected least-squares difference) was performed for multiple comparison.
| |
RESULTS |
|---|
|
|
|---|
Cell influx and body temperature changes induced by intraperitoneal
injection of casein. Figure 1A
shows the time course of the values of total PECs and peritoneal
neutrophils after injection of a 10% casein solution. To eliminate the
influence of circadian rhythms on leukocyte function (13, 40), PECs
were collected between 1200 and 1500. PEC values increased rapidly, and
a maximum response was observed 15 h after injection. At 5 h after the
injection, PECs contained mostly neutrophils (81.8 ± 0.3%) but
contained some of both neutrophils (63.5 ± 3.5%) and monocytes (33.8 ± 2.3%) at 15 h.
|
Body temperature fell suddenly after injection of 10% casein (Fig. 1B). Just before the casein injection, the average rectal temperature of mice was 38.0 ± 0.1°C and fell to 34.8 ± 0.6°C 1 h after the injection. On the other hand, saline injection did not cause rectal temperature to fall after 1 h (37.5 ± 0.4°C and 38.2 ± 0.5°C, before and 1 h after the injection, respectively). Until 3 h, temperature was still significantly lower in the casein-injected mice compared with saline-injected mice or with 0 h, but it recovered afterwards.
We examined the effects of 2% and 5% casein in addition to 10% casein, but no significant differences of body temperature from saline injection were observed nor was there neutrophil accumulation until 5 h after the smaller doses of casein injection (data not shown).
From these results, we deduced that intraperitoneal injection of 10% casein caused a rapid decrease in mouse body temperature and neutrophil accumulation during the restoration of body temperature.
TNF-
levels in PEFs after casein injection. PEFs were drawn
1 and 5 h after injection of saline or 2, 5, and 10% casein, and
TNF-
bioactivity was assessed (Table 1).
A dramatic elevation of TNF-
concentration was observed 1 h after
10% casein injection (632.83 ± 257.90 ng/ml). At 5 h, the TNF-
concentration had decreased but was still relatively high (92.53 ± 34.69 ng/ml). Casein at 2% and 5% did not cause significant release
of TNF-
at 1 and 5 h after injection.
|
To investigate the roles of internally elevated TNF-
on the changes
in body temperature and neutrophil infiltration, anti-TNF was applied 2 h before injection of 10% casein (Fig.
2A). Complete blockade of the
TNF-
activity in the PEF sample withdrawn 1 h after 10% casein
injection was confirmed by anti-TNF treatment using the above-mentioned
bioassay (data not shown). Anti-TNF itself had no effect on body
temperature before injection of casein. Also, body temperature
decreased 1 h after the injection of casein in the presence of anti-TNF
to the same extent as in the presence of saline (
2.82 ± 0.50°C vs.
2.85 ± 0.76°C from 0 h). However, anti-TNF
promoted restoration of body temperature, that is, significantly elevated body temperature 2 h after casein injection, whereas it takes
4 h to significantly recover temperature without anti-TNF pretreatment.
|
Anti-TNF pretreatment also partially inhibited neutrophil infiltration caused by injection of 10% casein (Fig. 2B). The number of peritoneal neutrophils was 9.24 (±1.76) × 106 cells in anti-TNF pretreatment and 19.81 (±3.09) × 106 cells in saline pretreatment 5 h after casein injection. In the case of anti-TNF pretreatment followed by saline injection, the number of peritoneal neutrophils was 2.03 (±0.29) × 106 cells.
It was therefore found that TNF-
, which was rapidly released into
the peritoneal cavity by casein injection, not only enhanced neutrophil
infiltration but also delayed recovery of decreased body temperature.
Effect of incubating temperature on apoptosis of neutrophils in
vitro. We next examined the direct effect of changes in temperature within a physiological range on apoptosis of neutrophils. PECs collected 5 h after injection of 10% casein were incubated at 37°C
or 35°C for up to 24 h in medium with or without the addition of
100 ng/ml rmTNF-
and stained with Giemsa. Apoptosis was determined by typical morphological features such as condensed nuclei, vacuolated cytoplasm, and some apoptotic bodies as described previously (16). Morphological features of apoptotic nuclei were also confirmed by
Hoechst 33258 staining (data not shown). As shown in Fig.
3A, the population of apoptotic
neutrophils was increased more rapidly at 37°C (on and after 6 h)
than at 35°C (on and after 18 h) in both the presence and the
absence of TNF-
. TNF-
accelerated ongoing apoptosis at 37°C
after 18 h, but not at 35°C until 24 h. We also cultured PECs at
39°C, and a significant increase of apoptotic neutrophils was
obtained during 3-12 h in culture compared with 37°C (data not
shown).
|
For biochemical estimation of apoptosis, DNA was isolated from PECs
cultured for 3 and 10 h at 37°C or 35°C and electrophoresed by
agarose gel. As shown in Fig. 4, the ladder
with ~200-bp typical steps of endonuclease activation did not appear
in DNA of PEC cultured for 3 h at both 37°C and 35°C (lanes
1-4), regardless of the presence or the absence of rmTNF-
.
However, typical ladders were observed in DNA of PEC cultured for 10 h
at 37°C in which the density of the ladder was greater in DNA of
PEC cultured with TNF-
(lane 6) than without TNF-
(lane 5). On the other hand, at 35°C, distinct ladders were
barely visible both in culture with or without TNF-
(lanes 7 and 8).
|
These results indicate that apoptosis of peritoneal neutrophils was
delayed as temperature of culture was lowered in a physiological range
and that the lower temperature also disturbed TNF-
-promoted neutrophil apoptosis.
To further examine whether lower temperature inhibition of apoptosis is restricted to inflammatory neutrophils or not, we next assessed apoptosis of neutrophils isolated from peripheral blood of intact mice. Equal to the peritoneal neutophils, incubation for 18 h at 35°C decreased both spontaneous and TNF-induced apoptosis of blood neutrophils compared with 37°C (Fig. 3B), thus suggesting that lower temperature suppresses neutrophil apoptosis in a neutrophil activation- or localization-independent manner.
Role of protein synthesis in temperature-dependent inhibition of
neutrophil apoptosis. To understand the mechanism by which a lower
temperature suppresses neutrophil apoptosis, 1 µg/ml CHX, a protein
synthesis inhibitor, was added to the PEC culture medium, which was
then cultured for 18 h at 37°C or 35°C (Fig.
5). Significant promotion of neutrophil
apoptosis was observed by the addition of CHX at 37°C (36.40 ± 3.46% vs. 23.85 ± 2.73% with or without CHX), but not at 35°C.
This suggests that the neutrophils synthesized apoptosis inhibitory
protein during culture at 37°C, but the lowered temperature
(35°C) suppressed apoptosis in a protein synthesis-independent manner.
|
Effect of incubating temperature on phagocytosis of peritoneal
neutrophils. Finally, to examine whether changes in temperature regulate not only neutrophil apoptosis but also its phagocytic function, PECs (2 × 105/ml) were incubated with
lumispheres (2 × 106/ml) in the presence or absence
of 100 ng/ml rmTNF-
at 37°C or 35°C for 20 min. As shown in
Table 2, in the absence of TNF-
, the
percentage of lumisphere-phagocytosing cells was significantly higher
at 35°C than at 37°C. We also counted the number of lumispheres per neutrophil, and the percentage of neutrophils phagocytosing more
than four particles was significantly higher at 35°C than at
37°C (data not shown). Addition of TNF-
, although not
significantly, tended to increase the phagocytosis by the same extents
(~1.1 times controls) at 37°C and 35°C. Accordingly, the
lower temperature was found to be beneficial in the promotion of
phagocytosis of peritoneal neutrophils.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, we demonstrated that intraperitoneal injection of
10% casein into mice induced a rapid decrease of rectal temperature,
which reached a maximum at 1 h after injection, followed by gradual
restoration by 15 h postinjection (Fig. 1B). During temperature
restoration, neutrophil infiltration into the peritoneal cavity
occurred and the population of neutrophils in total PECs reached a
maximum after 5 h (Fig. 1A). Kitamura et al. (20) demonstrated
the occurrence of a short-lasting fever after injecting 0.2% casein
into rabbits that caused the rectal temperature to increase for 90 min
after injection then peak at ~5 h (+0.8 ± 1.0 °C
compared with a baseline) and finally decreased to the control level by
12-24 h. Neutrophil accumulation, in their experiments, was
reported to reach a peak after 5 h, coinciding with our results. There
are many reports indicating that LPS administration induced mono- or
biphasic fever in various animals (22, 33). However, it has been
recently reported that larger doses of LPS induced hypothermia and
shock, whereas smaller doses caused fever in rats and mice (34).
Therefore, we examined the effects of 2% and 5% casein in addition to
10% casein, but hyperthermia was not detected by the two smaller doses
of casein (data not shown). In LPS-induced hypothermia, TNF-
has
been considered to function as a cryogen, although it was originally
thought to be a member of the endogenous pyrogens, because pretreatment
of animals with neutralizing anti-TNF antibody before LPS injection
resulted in enhancement of fever (26) or suppression of hypothermia
(6). Moreover, intraperitoneal injection of TNF-
has been reported to show an antipyretic effect on febrile response to LPS (21). Attenuation of hypothermia was also observed in TNFR knockout mice in
response to CLP, another model of sepsis (24). In our study, 10%
casein induced a dramatic rise in intraperitoneal TNF-
level during
the first hour, and a considerable amount of TNF-
was retained 5 h
after the injection (Table 1). Although anti-TNF pretreatment 2 h
before 10% casein injection did not block the casein-induced initial
decline of body temperature, it significantly promoted the restoration
of temperature to control values (Fig. 2A), indicating that
endogenous TNF-
released by casein injection limited the increase in
temperature during convalescence. It has been demonstrated that
LPS-induced hypothermia occurred as a result of reduced thermogenesis
(7), and Holt et al. (12) have reported that intracerebral injection of
recombinant TNF-
decreased the activity of sympathetic efferent
nerves to intercapular brown adipose tissue, a main effector of
nonshivering thermogenesis. It should be clarified whether TNF-retained
hypothermia in our inflammatory model occurred by the similar mechanism
in a future study. The primary inducer of the hypothermia after casein
injection is still uncertain, but other endogenous cryogens such as
-melanocyte-stimulating hormone, arginine-vasopressin,
glucocorticoid, leukotrienes, or prostaglandin D2 might be
involved in it (5, 6, 25, 27, 43).
Preinjection of anti-TNF partially decreased the 10% casein-induced
neutrophil accumulation (Fig. 2B), implying that TNF-
is
involved in the stimulation of neutrophils in the interstitial space
during inflammation. Such involvement of TNF-
in neutrophil infiltration was also reported by others using immune complex-induced inflammation of the murine peritoneum (50). This effect of TNF-
is
considered to be due to the stimulation of neutrophil-endothelial interaction, which is a pivotal event in neutrophil emigration from the
intravascular to inflammatory sites (11, 19).
Neutrophils exudated to local tissue are destined to undergo apoptosis
followed by recognition and phagocytosis by tissue macrophages (35).
Therefore, suppression of apoptosis contributes to maintenance of
neutrophil function, and many proinflammatory cytokines not only
enhance neutrophil function but also suppress the apoptosis (3, 10, 28,
39). TNF-
, however, has been reported to promote neutrophil
apoptosis (31, 39, 41, 42, 46) while enhancing the function (1, 28).
Because changes in body temperature are considered to alter
immune/inflammatory responses (22), we questioned whether they affect
neutrophil apoptosis. When PECs isolated from peritoneal cavities 5 h
after 10% casein injection were incubated at 35, 37, or 39°C,
significant decrease of neutrophil apoptosis was observed at 35°C
compared with 37°C (Fig. 3A) and at 37°C compared with
39°C (data not shown). Addition of 100 ng/ml rmTNF-
, which was
the approximate concentration in PEFs (5 h after the casein injection),
showed acceleration of neutrophil apoptosis when cultured at 37°C,
but not at 35°C (Fig. 3A). Because the peritoneal
neutrophils had already been exposed by various inflammatory mediators,
some of which promote apoptosis, whereas others antagonize apoptosis,
as stated above, we next did the same in vitro experiment by using
nonactivated neutrophils isolated from peripheral blood of intact mice
(Fig. 3B). Similar to the results of the peritoneal
neutrophils, spontaneous and TNF-
-induced apoptosis of blood
neutrophils were suppressed by the lower temperature, suggesting that
apoptotic response of neutrophils to temperature is in an inflammatory
activation- or neutrophil localization-independent manner. As we know,
this is the first report that temperature (within a physiological
range) affects neutrophil apoptosis, except for a report on heat
shock-induced apoptosis (46).
We then asked how body temperature regulates neutrophil apoptosis.
Neutrophils have been considered to synthesize apoptosis-inhibitory proteins, because addition of a protein synthesis inhibitor CHX to a
culture medium of neutrophils has been reported to accelerate neutrophil apoptosis (31, 42). Thus we examined the involvement of
protein synthesis in the lower temperature-induced suppression of
neutrophil apoptosis by incubating PECs for 18 h with or without CHX.
CHX apparently accelerated apoptosis of neutrophils at 37°C, but
apoptosis was not significantly changed for the control in the absence
of CHX compared with CHX at 35°C (Fig. 5), suggesting that
suppression of apoptosis at 35°C was caused in a protein synthesis-independent manner. Tsuchida et al. (42) reported that during
3 h incubation at 37°C, CHX did not enhance apoptosis of
rat peritoneal exudate neutrophils stimulated by proteose peptone injection. The discrepancy between their and our results on CHX action
might be due to the difference of incubation time (3 vs. 18 h).
Addition of CHX as well as TNF-
has been found to increase the
concentration of ceramide and its catabolite, sphingosine, a potent
endogenous protein kinase C inhibitor in neutrophils and other cells,
and these second messengers are suggested to play critical roles in
processes of apoptosis (32). Because the rate of sphingosine formation
has been demonstrated to increase with a rise of temperature (from
30°C to 37°C) (36), the lower temperature suppression of
apoptosis might involve the interruption of sphingosine formation.
Finally, we examined the effect of lower temperature on phagocytic
function of the peritoneal neutrophils. A significant increase in
lumisphere-ingesting neutrophils was obtained at 35°C, compared with 37°C (Table 2). TNF-
tended to slightly increase the
percentage at both 37°C and 35°C. The effect of temperature on
phagocytosis was examined earlier (15, 44, 45). Johansen et al. (15) reported that a moderate rise of temperature enhanced phagocytosis of
some (but not all) kinds of bacterial organisms by human peripheral blood neutrophils, whereas Utoh and Harasaki (44) showed no change of
phagocytosis of serum-opsonized latex particles by human and calf blood
neutrophils below 42°C. The diverse results might be caused by
obscurity in distinguishing phagocytosis from just attachment of the
particles or organisms to cells. With the use of hydrophilic
microsphere lumispheres, we recognized phagocytosis more easily and
accurately by the difference in staining nature of the particles
between intracellular and extracellular sites. As a possible mechanism
by which neutrophil phagocytosis is upregulated by the lower
temperature, less production of ceramide might be again related,
because ceramide has been reported to inhibit neutrophil phagocytosis
(38).
Taken together, we conclude that a rapid hypothermia occurs followed by
neutrophil infiltration into peritoneum after injection of inflammatory
stimuli in mice. Endogenously released TNF-
is suggested to regulate
not only neutrophil infiltration, but also body temperature to maintain
it slightly lower during neutrophil accumulation and function. Lowered
body temperature would suppress neutrophil apoptosis without protein
synthesis and upregulate neutrophil phagocytic function both by its own
effect and by negating the undesirable effect of TNF-
on
neutrophils. Further studies are essential to investigate the effect of
body temperature on other neutrophil function, such as superoxide and
cytokine production, and the mechanisms for how temperature regulates
neutrophil apoptosis and function.
Perspectives
As to the temperature effect on neutrophil function other than phagocytosis, previous studies have shown that a moderate (up to 40°C) rise of temperature results in rapid neutrophil migration; the opposite results were obtained with a hypothermic situation (45, 48). Because neutrophil accumulation, in our study, occurred during restoration period of hypothermia, elevation of temperature may be involved in enhancement of neutrophil infiltration into a casein-injected site. However, when anti-TNF was applied prior to casein injection, the number of peritoneal neutrophils was decreased despite a slight increase of body temperature. Thus it is so far uncertain to what extent the changes of temperature actually influenced neutrophil infiltration in our inflammatory model.Ensor et al. (8) have reported that high incubation temperature in a
physiological range downregulates the expression of TNF-
in
LPS-stimulated human macrophages derived from peripheral blood
monocytes in vitro. Thus cytokine production of neutrophils might also
be modulated by temperature. Moreover, on the basis of our data, it can
be speculated that TNF-
may prevent a suspension of its own
production by modulating a rise of body temperature in inflammation.
To investigate the temperature-induced intracellular events concerned in apoptosis or activation of neutrophils, concentrations and/or activity of ceramide, protein kinase C, or other second messengers should be assessed.
| |
ACKNOWLEDGEMENTS |
|---|
We appreciate Dr. Azumi Hamasaki for kind instruction of neutrophil
purification from blood and Drs. Tomoko Tajima and Shunji Kozaki for
agreeable offers of their experimental equipment. We also thank Seiko
Ishihara for technical help in the TNF-
bioassay.
| |
FOOTNOTES |
|---|
This work was supported by the University-to-University Cooperative Research Program (08045058) by the Ministry of Education, Science, Sports, and Culture of Japan, Grant-in-Aid (09660324) for Scientific Research C by the Ministry of Education, Science, Sports, and Culture of Japan, and by the Naito Foundation.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: Yukiko Kannan, Dept. of Veterinary Physiology, College of Agriculture, Osaka Prefecture University, 1-1 Gakuen-cho, Sakai, Osaka 599-8531, Japan (E-mail: kannan{at}vet.osakafu-u.ac.jp).
Received 26 January 1999; accepted in final form 11 August 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Berkow, R. L.,
D. Wang,
J. W. Larrick,
R. W. Dodson,
and
T. H. Howard.
Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.
J. Immunol.
139:
3783-3791,
1987[Abstract].
2.
Brummer, E.,
J. G. McEwen,
and
D. A. Stevens.
Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN.
Clin. Exp. Immunol.
66:
681-690,
1986[ISI][Medline].
3.
Colotta, F.,
F. Re,
N. Polentarutti,
S. Sozzani,
and
A. Mantovani.
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.
Blood
80:
2012-2020,
1992
4.
Cooper, A. L.,
S. Brouwer,
A. V. Turnbull,
G. N. Luheshi,
S. J. Hopkins,
S. L. Kunkel,
and
N. J. Rothwell.
Tumor necrosis factor-
and fever after peripheral inflammation in the rat.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
267:
R1431-R1436,
1994
5.
Davidson, J.,
A. S. Milton,
and
D. Rotondo.
Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit.
J. Physiol. (Lond.)
451:
491-602,
1992
6.
Derijk, R. H.,
and
F. Berkenbosch.
Hypothermia to endotoxin involves the cytokine tumor necrosis factor and the neuropeptide vasopressin in rats.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
266:
R9-R14,
1994
7.
Derijk, R. H.,
M. V. Kampen,
N. V. Rooijen,
and
F. Berkenbosch.
Hypothermia to endotoxin involves reduced thermogenesis, macrophage-dependent mechanisms, and prostaglandins.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
266:
R1-R8,
1994
8.
Ensor, J. E.,
S. M. Wiener,
K. A. McCrea,
R. M. Viscardi,
E. K. Crawford,
and
J. D. Hasday.
Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-
expression.
Am. J. Physiol. Cell Physiol.
266:
C967-C974,
1994
9.
Flick, D. A.,
and
G. E. Gifford.
Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.
J. Immunol. Methods
68:
167-175,
1984[ISI][Medline].
10.
Girard, D.,
M. E. Paquet,
R. Paquin,
and
A. D. Beaulieu.
Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15.
Blood
88:
3176-3184,
1996
11.
Hickey, M. J.,
P. H. Reinhardt,
L. Ostrovsky,
W. M. Jones,
M. A. Jutila,
D. Payne,
J. Elliott,
and
P. Kubes.
Tumor necrosis factor-
induced leukocyte recruitment by different mechanisms in vivo and in vitro.
J. Immunol.
158:
3391-3400,
1997[Abstract].
12.
Holt, S. J.,
R. F. Grimble,
and
D. A. York.
Tumor necrosis factor-
and lymphotoxin have opposite effects on sympathetic efferent nerves to brown adipose tissue by direct action in the central nervous system.
Brain Res.
497:
183-186,
1989[ISI][Medline].
13.
House, S. D.,
S. Ruch,
W. F. Koscienski, III,
C. W. Rocholl,
and
R. L. Moldow.
Effects of the circadian rhythm of corticosteroids on leukocyte-endothelium interactions in the AM and PM.
Life Sci.
60:
2023-2034,
1997[ISI][Medline].
14.
Ishizawa, M.,
Y. Kobayashi,
T. Miyamura,
and
S. Matsuura.
Simple procedure of DNA isolation from human serum.
Nucleic Acids Res.
19:
5792-6656,
1991
15.
Johansen, K. S.,
E. M. Johansen,
and
J. E. Repine.
Effect of temperature on polymorphonuclear leukocyte function.
Acta. Path. Microbiol. Immunol. Scand. Sect. C.
91:
355-359,
1983[ISI][Medline].
16.
Kannan, Y.,
K. Usami,
M. Okada,
S. Shimizu,
and
H. Matsuda.
Nerve growth factor suppresses apoptosis of murine neutrophils.
Biochem. Biophys. Res. Commun.
186:
1050-1056,
1992[ISI][Medline].
17.
Kannan, Y.,
H. Ushio,
H. Koyama,
M. Okada,
M. Oikawa,
T. Yoshihara,
M. Kaneko,
and
H. Matsuda.
2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils.
Blood
77:
1320-1325,
1991
18.
Kawasaki, H.,
M. Moriyama,
Y. Ohtani,
M. Naitoh,
A. Tanaka,
and
H. Nariuchi.
Analysis of endotoxin fever in rabbits by using a monoclonal antibody to tumor necrosis factor (cachectin).
Infect. Immun.
57:
3131-3135,
1989
19.
Kilgore, K. S.,
J. P. Shen,
B. F. Miller,
P. A. Ward,
and
J. S. Warren.
Enhancement by the complement membrane attack complex of tumor necrosis factor-
-induced endothelial cell expression of E-selectin and ICAM-1.
J. Immunol.
155:
1434-1441,
1995[Abstract].
20.
Kitamura, M.,
F. Goto,
S. Ohkawara,
and
M. Yoshinaga.
Production of pyrogen by polymorphonuclear leukocytes during the course of casein-induced peritonitis in rabbits.
Acta Pathol. Jpn.
36:
791-803,
1986[Medline].
21.
Klir, J. J.,
J. L. McClellan,
W. Kozak,
Z. Szelényi,
G. H. W. Wong,
and
M. J. Kluger.
Systemic but not central administration of tumor necrosis factor-
attenuates LPS-induced fever in rats.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
268:
R480-R486,
1995
22.
Kluger, M. J.
Fever: role of pyrogens and cryogens.
Physiol. Rev.
71:
93-127,
1991[Abstract].
23.
Kozak, W.,
D. Soszynski,
K. Rudolph,
L. R. Leon,
C. A. Conn,
and
M. J. Kluger.
Soluble tumor necrosis factor-
receptor prevents decrease of body temperature in mice treated with indomethacin and lipopolysaccharide.
Ann. N.Y. Acad. Sci.
813:
264-271,
1997[Medline].
24.
Leon, L. R.,
A. A. White,
and
M. J. Kluger.
Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
275:
R269-R277,
1998
25.
Lin, M. T.,
J. H. Lin,
and
Y. L. Yang.
Dexamethasone administered into organum vasculosum laminae terminalis of rabbits induced antipyresis via inhibiting nitric oxide pathway in situ.
Neurosci. Lett.
230:
53-56,
1997[ISI][Medline].
26.
Long, N. C.,
S. L. Kunkel,
A. J. Vander,
and
M. J. Kluger.
Antiserum against TNF enhances LPS fever in the rat.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
258:
R332-R337,
1990
27.
Martin, L. W.,
A. Catania,
M. E. Hiltz,
and
J. M. Lipton.
Neuropeptide alpha-MSH antagonizes IL-6- and TNF-induced fever.
Peptides
12:
297-299,
1991[ISI][Medline].
28.
Moxey-Mims, M. M.,
H. H. Simms,
M. M. Frank,
E. Y. Lin,
and
T. A. Gaither.
The effects of IL-1, IL-2, and tumor necrosis factor on polymorphonuclear leukocyte Fc
receptor-mediated phagocytosis: IL-2 down-regulates the effect of tumor necrosis factor.
J. Immunol.
147:
1823-1830,
1991[Abstract].
29.
Nagai, M.,
T. Saigusa,
Y. Shimada,
H. Inagawa,
H. Oshima,
and
M. Iriki.
Antibody to tumor necrosis factor (TNF) reduces endotoxin fever.
Experientia
44:
606-607,
1988[ISI][Medline].
30.
Nakamura, H.,
Y. Seto,
S. Motoyoshi,
T. Kadokawa,
and
N. Sunahara.
Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.
J. Pharmacol. Exp. Ther.
245:
336-341,
1988
31.
Niwa, M.,
A. Hara,
Y. Kanamori,
K. Kohno,
N. Yoshimi,
H. Mori,
and
T. Uematsu.
Comparison of susceptibility to apoptosis induced by rhTNF-
and cycloheximide between human circulating and exudated neutrophils.
Life Sci.
61:
205-215,
1997[ISI][Medline].
32.
Ohta, H.,
Y. Yatomi,
E. A. Sweeney,
S. Hakomori,
and
Y. Igararashi.
A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-
in human neutrophils.
FEBS Lett.
355:
267-270,
1994[ISI][Medline].
33.
Romanovsky, A. A.,
and
C. M. Blatteis.
Biphasic fever: what triggers the second temperature rise?
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
269:
R280-R286,
1995
34.
Romanovsky, A. A.,
O. Shido,
S. Sakurada,
N. Sugimoto,
and
T. Nagasaka.
Endotoxin shock: thermoregulatory mechanisms.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
270:
R693-R703,
1996
35.
Savill, J. S.,
A. H. Wyllie,
J. E. Henson,
M. J. Walport,
P. M. Henson,
and
C. Haslett.
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.
J. Clin. Invest.
83:
865-875,
1989.
36.
Slife, C. W.,
E. Wang,
R. Hunter,
S. Wang,
and
C. Burgess.
Free sphingosine formation from endogenous substrates by a liver plasma membrane system with a divalent cation dependence and a neutral pH optimum.
J. Biol. Chem.
264:
10371-10377,
1989
37.
Spriggs, D. R.,
M. L. Sherman,
E. Frei, III,
and
D. W. Kufe.
Clinical studies with tumor necrosis factor.
Ciba Found. Symp.
131:
206-227,
1987[Medline].
38.
Suchard, S. J.,
V. Hinkovska-Galcheva,
P. J. Mansfield,
L. A. Boxer,
and
K. A. Shayman.
Ceramide inhibits IgG-dependent phagocytosis in human polymorphonuclear leukocytes.
Blood
89:
2139-2147,
1997
39.
Sullivan, G. W.,
A. K. Gelrud,
H. T. Carper,
and
G. L. Mandell.
Interaction of tumor necrosis factor-alpha and granulocyte colony-stimulating factor on neutrophil apoptosis, receptor expression, and bactericidal function
Proc. Assoc. Am. Physicians
108:
455-466,
1996[ISI][Medline].
40.
Suzuki, S.,
S. Toyabe,
T. Moroda,
T. Tada,
A. Tsukahara,
T. Iiai,
M. Minagawa,
S. Maruyama,
K. Hatakeyama,
K. Endoh,
and
T. Abo.
Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system.
Clin. Exp. Immunol.
110:
500-508,
1997[ISI][Medline].
41.
Takeda, Y.,
H. Watanabe,
S. Yonehara,
T. Yamashita,
S. Saito,
and
F. Sendo.
Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-
.
Int. Immunol.
5:
691-694,
1993
42.
Tsuchida, H.,
Y. Takeda,
H. Takei,
H. Shinzawa,
T. Takahashi,
and
F. Sendo.
In vivo regulation of rat neutrophil apoptosis occurring spontaneously or induced with TNF-
or cycloheximide.
J. Immunol.
154:
2403-2412,
1995[Abstract].
43.
Ueno, R.,
S. Narumiya,
T. Ogorochi,
T. Nakayama,
T. Ishikawa,
and
O. Hayashi.
Role of prostaglandin D2 in the hypothermia of rats caused by bacterial lipopolysaccharide.
Proc. Natl. Acad. Sci. USA.
79:
6093-6097,
1992.
44.
Utoh, J.,
and
H. Harasaki.
Effects of temperature on phagocytosis of human and calf polymorphonuclear leukocytes.
Artif. Organs
16:
377-381,
1992[ISI][Medline].
45.
Van Oss, C. J.,
D. R. Absolom,
L. L. Moore,
B. H. Park,
and
J. R. Humbert.
Effect of temperature on the chemotaxis, phagocytic engulfment, digestion, and O2 consumption of human polymorphonuclear leukocytes.
J. Reticuloendoth. Soc.
27:
561-565,
1980[ISI][Medline].
46.
Watson, R. W.,
H. P. Redmond,
J. H. Wang,
and
D. Bouchier-Hayes.
Bacterial ingestion, tumor necrosis factor-alpha, and heat induce programmed cell death in activated neutrophils.
Shock
5:
47-51,
1996[ISI][Medline].
47.
Wenisch, C.,
E. Narzt,
D. I. Sessler,
B. Parschalk,
R. Lenhardt,
A. Kurz,
and
W. Graninger.
Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes.
Anesth. Analg.
82:
810-816,
1996[Abstract].
48.
Whalen, M. J.,
T. M. Carlos,
R. S. Clark,
D. W. Marion,
M. S. DeKosky,
S. Heineman,
J. K. Schiding,
F. Memarzadeh,
C. E. Dixon,
and
P. M. Kochanek.
The relationship between brain temperature and neutrophil accumulation after traumatic brain injury in rats.
Acta. Neurochir. Suppl.
70:
260-261,
1997[Medline].
49.
Yee, J.,
B. Giannias,
B. Kapadia,
L. Chartrand,
and
N. V. Christou.
Exudative neutrophils. Modulation of microbicidal function in the inflammatory microenvironment.
Arch. Surg.
129:
99-105,
1994[Abstract].
50.
Zhang, Y.,
B. F. Ramos,
and
B. A. Jakschik.
Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis.
Science
258:
1957-1959,
1992
This article has been cited by other articles:
![]() |
Y. Sakakura, H. Sato, A. Shiiya, M. Tamba, J.-i. Sagara, M. Matsuda, N. Okamura, N. Makino, and S. Bannai Expression and function of cystine/glutamate transporter in neutrophils J. Leukoc. Biol., April 1, 2007; 81(4): 974 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Fairchild, I. S. Singh, H. C. Carter, L. Hester, and J. D. Hasday Hypothermia enhances phosphorylation of I{kappa}B kinase and prolongs nuclear localization of NF-{kappa}B in lipopolysaccharide-activated macrophages Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1114 - C1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pfister, M. Ollert, L. F. Frohlich, L. Quintanilla-Martinez, T. V. Colby, U. Specks, and D. E. Jenne Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo Blood, September 1, 2004; 104(5): 1411 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Buhimschi and C. P. Weiner ENDOTOXEMIA CAUSING FETAL BRADYCARDIA DURING UROSEPSIS Obstet. Gynecol., May 1, 2001; 97(5): 818 - 820. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||